Determining the effect of sodium levels of dialysis fluid on the levels of calcium, phosphorus and parathyroid hormone in patients undergoing chronic hemodialysis
Phase 3
Recruiting
- Conditions
- Patients undergoing chronic hemodialysis.
- Registration Number
- IRCT20231217060445N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Chronic hemodialysis patients aged 18 to 60 years
Exclusion Criteria
The presence of any uncontrolled underlying disease (such as pheochromocytoma or other cardio-pulmonary and liver diseases)
Presence of active infection
Occurrence of frequent muscle cramps that cannot be found due to low sodium.
Patient's sodium is less than 130 mEq/L
Systolic or diastolic blood pressure drop of more than 20 mm Hg compared to the patient's baseline pressure.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Calcium. Timepoint: Before starting the study, one and three months after dialysis. Method of measurement: blood test.;Phosphorus. Timepoint: Before starting the study, one and three months after dialysis. Method of measurement: Blood test.;Parathyroid hormone. Timepoint: Before starting the study, one and three months after dialysis. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method